Aaron Cowley has been the Chief Scientific Officer at ReciBioPharm since November 2019. With more than 20 years of experience in the biotech and pharmaceutical industries, Aaron is known for his ability to drive innovation while maintaining scientific rigor. His leadership is built on a strong technical expertise and foundation in strategic thinking.